Kai-Hua, Edward Chow

Chow Kai-Hua, Edward

Appointment(s)
  • Assistant Professor, Department of Surgery
  • Consultant, Department of Cardiac, Thoracic & Vascular Surgery, University Surgical Cluster, National University Health System
Administrative Appointment(s)
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, University of California, Los Angeles, USA
  • BA, University of California, Berkeley, USA
Research Interest(s)
  • Cancer Stem Cells
  • Nanomedicine
  • Therapeutic Combination Optimisation
  • Epigenetics
  • Hematologic Malignancies
Recent Publications
  • 1. Wang X, Gu M, Toh TB, Abdullah NLB, Chow EKH. 2018 Feb. Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection. SLAS Technol. 23(1):44-56. doi: 10.1177/2472630317735497.
  • 2. Lee DK, Kee T, Liang Z, Hsiou D, Miya D, Wu B, Osawa E, Chow EKH, Sung EC, Kang MK et al. 2017 Nov. Clinical validation of a nanodiamond-embedded thermoplastic biomaterial. Proceedings of the National Academy of Sciences of the United States of America. 114(45):E9445-E9454. doi: 10.1073/pnas.1711924114.
  • 3. Ho JC, Abdullah LN, Pang QY, Jha S, Chow EKH, Yang H, Kato H, Poellinger L, Ueda J, Lee KL. 2017 Nov. Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway. PLoS One. 12(11): e0188051. doi: 10.1371/journal.pone.0188051.
  • 4. Chow EKHW. 2017 Aug. Welcome to the Digital World of Quantitative Biology. SLAS Technology. 22(4):367-368. doi: 10.1177/2472630317713262.
  • 5. Fong ELS, Toh TB, Yu H, Chow EKH. 2017 Jun. 3D Culture as a Clinically Relevant Model for Personalized Medicine. SLAS Technology. 22(3):245-253. doi: 10.1177/2472630317697251.